Noel Anderson( middle), Sirsij Peshin( right) but it taught us what to do when a crisis hits. And I think what we are facing today is no less than COVID, but we’ ve had those couple of iterations before, and as teams, we know how to address some of the challenges that geopolitics and tariffs drive for the world.
Bringing it back to Pfizer, there are a couple of things I find really impressive. One is from a responsible business growth perspective, we don’ t call it ESG, we call it responsible business growth.
It really is driven at the board level, and there is a board commitment to delivering on those targets. What I’ m really proud of is that over the last couple of years, we have delivered US $ 4bn of aggregate spend towards small businesses across the world, which is phenomenal and is really impacting broader communities. We are also overachieving many of our suppliers’ science-based targets – 70 % of our suppliers by spend now have an SBTi goal. What I’ m trying to get to is that in order to have that impact, you need not just sponsorship but a framework that starts with governance, tools, commitment and change management, so that we are, as an enterprise, driving the agenda towards where we want to be.
procurementmag. com 91